Dawson James Securities Announces the Closing of Public Offering for Sigma Labs, Inc. for Gross Proceeds of $2,390,000

BOCA RATON, Fla., June 27, 2018 (GLOBE NEWSWIRE) — Dawson James Securities, Inc. in conjunction with Sigma Labs, Inc. (NASDAQ:SGLB) completed a registered direct offering of 2,390,000 units consisting of one share of common stock and 30% of a warrant to purchase a share of common stock at a price of $1.00 per unit.  The warrants are immediately exercisable at a price of $1.08 per share of common stock and will expire on the fifth anniversary of the date of issuance.  To the extent that the purchase of shares of common stock would result in beneficial ownership above 4.99%, an investor could elect to purchase shares of the Company’s Series C Convertible Preferred Stock in lieu of common stock.  Each share of preferred stock has no dividend rights.  The offering closed on June 26th, 2018.   

The Company intends to use the net proceeds from the offering for general working capital and corporate purposes.  Dawson James Securities, Inc. acted as sole placement agent for the offering. 

The shares described above were offered by Sigma Labs, Inc. pursuant to a registration statement on Form S-3 previously filed with, and subsequently declared effective by, the Securities and Exchange Commission (“SEC”). A final prospectus supplement relating to the offering was filed with the SEC and is available, along with the accompanying base prospectus, on the SEC’s website at http://www.sec.gov, or by contacting Dawson James:  1 N. Federal Hwy; Suite 500, Boca Raton, FL 33432 ATTN:  Prospectus Department.

About Sigma Labs

Sigma Labs, Inc. is a provider of quality assurance software under the PrintRite3D® brand and a developer of advanced, in-process, non-destructive quality assurance software for commercial firms worldwide seeking productive solutions for advanced manufacturing.  www.sigmalabsinc.com   

About Dawson James Securities

Dawson James Securities specializes in capital raising for small and microcap public and private growth companies primarily in the Life Science/Health Care, Technology and Consumer sectors and is a full-service investment banking firm with research, institutional and retail sales, and execution trading and corporate services.  Headquartered in Boca Raton, FL, Dawson James is privately held with offices in New York, Maryland and New Jersey. www.dawsonjames.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:  This news release may contain forward-looking information within the meaning of Section 27A Of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes”, “expects”, “anticipates” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.  

Member FINRA/SIPC.   For more information, please contact:

Elise Stern, Managing Director, Head of Capital Markets
estern@dawsonjames.com
561-208-2926